Chujo T, Tomizawa K
RNA. 2024; 31(3):382-394.
PMID: 39719325
PMC: 11874988.
DOI: 10.1261/rna.080257.124.
Maharjan S, Gamper H, Yamaki Y, Christian T, Henley R, Li N
Nat Commun. 2024; 15(1):9008.
PMID: 39424798
PMC: 11489592.
DOI: 10.1038/s41467-024-53318-x.
Horna S, Pec M, Krivus J, Michalova R, Sivak S, Galajda P
Eur J Case Rep Intern Med. 2024; 11(2):004268.
PMID: 38352812
PMC: 10860911.
DOI: 10.12890/2024_004268.
Chen D, Li W, Jiang H, Yuan C
Front Neurol. 2023; 14:1179992.
PMID: 37576015
PMC: 10413099.
DOI: 10.3389/fneur.2023.1179992.
Tomoda E, Nagao A, Shirai Y, Asano K, Suzuki T, Battersby B
Nucleic Acids Res. 2023; 51(14):7563-7579.
PMID: 36928678
PMC: 10415153.
DOI: 10.1093/nar/gkad139.
Modifications of the human tRNA anticodon loop and their associations with genetic diseases.
Zhou J, Wang E, Zhou X
Cell Mol Life Sci. 2021; 78(23):7087-7105.
PMID: 34605973
PMC: 11071707.
DOI: 10.1007/s00018-021-03948-x.
The expanding world of tRNA modifications and their disease relevance.
Suzuki T
Nat Rev Mol Cell Biol. 2021; 22(6):375-392.
PMID: 33658722
DOI: 10.1038/s41580-021-00342-0.
The molecular pathology of pathogenic mitochondrial tRNA variants.
Richter U, McFarland R, Taylor R, Pickett S
FEBS Lett. 2021; 595(8):1003-1024.
PMID: 33513266
PMC: 8600956.
DOI: 10.1002/1873-3468.14049.
Hijacking tRNAs From Translation: Regulatory Functions of tRNAs in Mammalian Cell Physiology.
Avcilar-Kucukgoze I, Kashina A
Front Mol Biosci. 2021; 7:610617.
PMID: 33392265
PMC: 7773854.
DOI: 10.3389/fmolb.2020.610617.
Inheritance of mitochondrial DNA in humans: implications for rare and common diseases.
Wei W, Chinnery P
J Intern Med. 2020; 287(6):634-644.
PMID: 32187761
PMC: 8641369.
DOI: 10.1111/joim.13047.
Mitochondrial dysfunction and its role in tissue-specific cellular stress.
Pacheu-Grau D, Rucktaschel R, Deckers M
Cell Stress. 2019; 2(8):184-199.
PMID: 31225486
PMC: 6551628.
DOI: 10.15698/cst2018.07.147.
Clinical diagnosis in the era of DNA testing.
Brodie S
Doc Ophthalmol. 2019; 138(3):167-168.
PMID: 30924004
DOI: 10.1007/s10633-019-09689-4.
Retinal dystrophy associated with a single-base deletion mutation in mitochondrial DNA 3271 in patient with MELAS syndrome.
Ozawa K, Mochizuki K, Manabe Y, Yoshikura N, Shimohata T, Nishino I
Doc Ophthalmol. 2019; 138(2):147-152.
PMID: 30701423
DOI: 10.1007/s10633-019-09673-y.
Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial.
Ohsawa Y, Hagiwara H, Nishimatsu S, Hirakawa A, Kamimura N, Ohtsubo H
J Neurol Neurosurg Psychiatry. 2018; 90(5):529-536.
PMID: 29666206
PMC: 6581075.
DOI: 10.1136/jnnp-2018-317964.
Analysis of mitochondrial function in human induced pluripotent stem cells from patients with mitochondrial diabetes due to the A3243G mutation.
Matsubara M, Kanda H, Imamura H, Inoue M, Noguchi M, Hosoda K
Sci Rep. 2018; 8(1):949.
PMID: 29343702
PMC: 5772054.
DOI: 10.1038/s41598-018-19264-7.
Nucleoside modifications in the regulation of gene expression: focus on tRNA.
Duechler M, Leszczynska G, Sochacka E, Nawrot B
Cell Mol Life Sci. 2016; 73(16):3075-95.
PMID: 27094388
PMC: 4951516.
DOI: 10.1007/s00018-016-2217-y.
A complete landscape of post-transcriptional modifications in mammalian mitochondrial tRNAs.
Suzuki T, Suzuki T
Nucleic Acids Res. 2014; 42(11):7346-57.
PMID: 24831542
PMC: 4066797.
DOI: 10.1093/nar/gku390.
Endocrine disorders in mitochondrial disease.
Schaefer A, Walker M, Turnbull D, Taylor R
Mol Cell Endocrinol. 2013; 379(1-2):2-11.
PMID: 23769710
PMC: 3820028.
DOI: 10.1016/j.mce.2013.06.004.
The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress.
Martinc B, Grabnar I, Vovk T
Curr Neuropharmacol. 2013; 10(4):328-43.
PMID: 23730257
PMC: 3520043.
DOI: 10.2174/157015912804143504.
The m.3291T>C mt-tRNA(Leu(UUR)) mutation is definitely pathogenic and causes multisystem mitochondrial disease.
Yarham J, Blakely E, Alston C, Roberts M, Ealing J, Pal P
J Neurol Sci. 2013; 325(1-2):165-9.
PMID: 23273904
PMC: 3560033.
DOI: 10.1016/j.jns.2012.12.003.